Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulants”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06224907
What this trial is testing

Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
BioMarin Pharmaceutical 6
Not applicableStudy completedNCT01809015
What this trial is testing

Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme

Who this might be right for
Anticoagulant Antagonists, Vitamin K and Other Coagulants Causing Adverse Effects in Therapeutic UseAtrial FibrillationVenous Thromboembolism
Johannes Gutenberg University Mainz 2,318
Post-approval studies (Phase 4)Study completedNCT04483583
What this trial is testing

Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI

Who this might be right for
Coronary Artery Disease
University of Florida 81
Testing effectiveness (Phase 2)Study completedNCT04865978
What this trial is testing

Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices

Who this might be right for
Heart Failure
Palak Shah 30
Very early researchWithdrawnNCT04355832
What this trial is testing

Glucagon-like Peptide-1 in Type 1 Diabetes

Who this might be right for
Type1 Diabetes Mellitus
University of Maryland, Baltimore
Not applicableTemporarily pausedNCT01305148
What this trial is testing

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)

Who this might be right for
Anti-coagulation TherapyDVTPulmonary Embolism+3 more
Iverson Genetic Diagnostics, Inc. 3,800
Large-scale testing (Phase 3)Study completedNCT01675076
What this trial is testing

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events

Who this might be right for
Hematoma
Ottawa Heart Institute Research Corporation 663
Post-approval studies (Phase 4)Study completedNCT01873768
What this trial is testing

Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement

Who this might be right for
Osteoarthritis
Miller Orthopedic Specialists 194
Not applicableStudy completedNCT03254147
What this trial is testing

Medical Need of OAC Reversal

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 53,969
Large-scale testing (Phase 3)Study completedNCT02072434
What this trial is testing

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 2,199
Testing effectiveness (Phase 2)Study completedNCT01227187
What this trial is testing

Safety and Dose Finding Study of Xigris in Hemodialysis Patients

Who this might be right for
End Stage Renal Disease
George Washington University 12
Not applicableEnded earlyNCT03645564
What this trial is testing

Impact of the Information Follow-up Given to Patients on Their Disease Understanding and Therapeutic Adherence in Patients Under Direct Oral Anticoagulants and With Atrial Fibrillation in a Cardiology Department

Who this might be right for
Atrial Fibrillation
University Hospital, Bordeaux 221
Post-approval studies (Phase 4)Study completedNCT04006288
What this trial is testing

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
University of Florida 90
Post-approval studies (Phase 4)Ended earlyNCT01569035
What this trial is testing

Warfarine in Unexplained Oligohydramnios

Who this might be right for
Oligohydramnios
Woman's Health University Hospital, Egypt 200
Testing effectiveness (Phase 2)Ended earlyNCT03520712
What this trial is testing

Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5

Who this might be right for
Hemophilia AGene TherapyClotting Disorders+1 more
BioMarin Pharmaceutical 3
Large-scale testing (Phase 3)Study completedNCT04655586
What this trial is testing

Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19

Who this might be right for
Covid19
ARCA Biopharma, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT02576795
What this trial is testing

Gene Therapy Study in Severe Haemophilia A Patients (270-201)

Who this might be right for
Severe Haemophilia A
BioMarin Pharmaceutical 15
Large-scale testing (Phase 3)Study completedNCT02040428
What this trial is testing

The Fibrin Pad CV Phase III Study

Who this might be right for
Cardiovascular Disease
Ethicon, Inc. 156
Not applicableStudy completedNCT02987946
What this trial is testing

Leiden Trial in Prevention of Post-Operative ThromboEmbolic Events

Who this might be right for
Deep-Venous Thrombosis
Leiden University Medical Center 280
Testing effectiveness (Phase 2)Study completedNCT04684940
What this trial is testing

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia A With Anti Factor VIII
BioMarin Pharmaceutical 10
Next Page